These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15540222)
41. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma. Nakahata S; Saito Y; Hamasaki M; Hidaka T; Arai Y; Taki T; Taniwaki M; Morishita K Genes Chromosomes Cancer; 2009 Sep; 48(9):768-76. PubMed ID: 19484761 [TBL] [Abstract][Full Text] [Related]
42. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression. Baudis M; Prima V; Tung YH; Hunger SP Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189 [TBL] [Abstract][Full Text] [Related]
44. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation. Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877 [TBL] [Abstract][Full Text] [Related]
45. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells. Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359 [TBL] [Abstract][Full Text] [Related]
46. Ectopic expression of the HLXB9 gene is associated with an altered nuclear position in t(7;12) leukaemias. Ballabio E; Cantarella CD; Federico C; Di Mare P; Hall G; Harbott J; Hughes J; Saccone S; Tosi S Leukemia; 2009 Jun; 23(6):1179-82. PubMed ID: 19212340 [No Abstract] [Full Text] [Related]
47. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2. Lahortiga I; Belloni E; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Valgañón M; Zudaire I; Sáez B; Mateos MC; Di Fiore PP; Calasanz MJ; Odero MD Cancer Genet Cytogenet; 2005 Mar; 157(2):151-6. PubMed ID: 15721637 [TBL] [Abstract][Full Text] [Related]
48. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis. Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565 [TBL] [Abstract][Full Text] [Related]
49. A new cytogenetic abnormality, t(2;7)(q33;q36), in acute promyelocytic leukemia. Owatari S; Uozumi K; Haraguchi K; Ohno N; Tokunaga M; Tokunaga M; Suzuki S; Hanada S; Arima N Cancer Genet Cytogenet; 2007 Feb; 173(1):71-4. PubMed ID: 17284374 [TBL] [Abstract][Full Text] [Related]
50. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans. Larson RA; Le Beau MM Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816 [TBL] [Abstract][Full Text] [Related]
51. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia. Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060 [TBL] [Abstract][Full Text] [Related]
52. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21). Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339 [TBL] [Abstract][Full Text] [Related]
53. Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia. Tosi S; Ballabio E; Teigler-Schlegel A; Boultwood J; Bruch J; Harbott J Genes Chromosomes Cancer; 2005 Nov; 44(3):225-32. PubMed ID: 16028218 [TBL] [Abstract][Full Text] [Related]
54. [Expression of EDAG-1 gene in human leukemia and lymphoma cell lines]. Zhou Y; Xu WX; Zhan YQ; Li CY; Xu CW; Zheng H; Li FF; Yang XM; Wang SY Ai Zheng; 2004 Nov; 23(11):1238-43. PubMed ID: 15522166 [TBL] [Abstract][Full Text] [Related]
55. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032 [TBL] [Abstract][Full Text] [Related]
56. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907 [TBL] [Abstract][Full Text] [Related]
57. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences. Kasashima K; Sakota E; Kozu T Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282 [TBL] [Abstract][Full Text] [Related]
58. Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells. Wildenhain S; Ingenhag D; Ruckert C; Degistirici Ö; Dugas M; Meisel R; Hauer J; Borkhardt A J Biol Chem; 2012 Nov; 287(48):40703-12. PubMed ID: 23048027 [TBL] [Abstract][Full Text] [Related]